Fredun Pharmaceuticals Limited has submitted a regulatory disclosure to BSE Limited regarding compliance with SEBI Listing Regulations. The company is sending letters to shareholders whose email addresses are not registered with the company, registrar, or depository participants. These letters provide the exact web link where the Annual Report for FY 2025-26 and the Notice convening the 39th Annual General Meeting can be accessed.
The 39th Annual General Meeting is scheduled to be held on Tuesday, 30th June 2026 at 9:00 AM IST through Video Conferencing facility/Other Audio Visual Means.
The web link provided for accessing the Annual Report is: http://www.fredungroup.com/investor-annual-report.html#investor
This communication is specifically targeted at members who had not registered their email addresses as of the cut-off date Friday, 29th May 2026.
The disclosure also serves as a reminder to shareholders to update KYC details pursuant to SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 07, 2024, and to dematerialize physical securities. The SEBI circular mandates that listed companies must record PAN, address with PIN code, mobile number, bank account details, specimen signature, and choice of nomination for security holders holding securities in physical mode.
Shareholders holding physical shares whose folios do not have updated PAN, choice of nomination, contact details, bank account details, and specimen signature are eligible for payments (including dividend, interest, or redemption) only through electronic mode effective from April 1, 2024.
Shareholder queries can be directed to Purva Sharegistry (India) Private Limited at support@purvashare.com or through their website at https://purvashare.com/investor/login/ or by phone at 022 4134 3255 / 56.
The document is signed by Fredun Nariman Medhora, Managing Director and CFO (DIN: 01745348), and includes his digital signature with authentication details.